Nephrogenic systemic fibrosis - PDFSEARCH.IO - Document Search Engine

Nephrogenic systemic fibrosis
Results: 47

#	Item
21	[removed]Gadobendate Clinical PREA Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadopentetic acid Gadodiamide Magnetic resonance imaging MRI contrast agent Nephrogenic systemic fibrosis Gadobenic acid Chemistry Matter Medicine
22	Pediatric Focused Safety Review: MultiHance Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Boxed warning Food and Drug Administration Gadobenic acid Gadopentetic acid Gadodiamide Chemistry Matter Medicine
23	[removed]Gadobutrol Clinical PREA Add to Reading List Source URL: www.fda.gov Language: English Gadopentetic acid Gadolinium MRI contrast agent Magnetic resonance imaging Gadodiamide Food and Drug Administration Brain tumor Nephrogenic systemic fibrosis Chemistry Medicine Matter
24	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EOVIST® Injection safely and effectively. See full prescribing information for EOVIST Injection. EOVIST (Gadoxetate Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:30:47 Nephrogenic systemic fibrosis Nephrology Gadolinium Lorazepam Magnetic resonance imaging MRI contrast agent Flucytosine Chemistry Matter Organochlorides
25	The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological saline Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:38:58 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Radiocontrast agent Ketorolac Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Gadodiamide
26	Multihance (gadobenate dimeglumine) injection label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 13:20:36 Gadodiamide Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Medicine
27	Ablavar (gadofosveset trisodium) solution label Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-12-21 10:25:06 Nephrogenic systemic fibrosis Nephrology Gadolinium Magnetic resonance imaging MRI contrast agent Gadodiamide Chemistry Matter Medicine
28	OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013 Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-05-23 16:04:28 Medicine MRI contrast agent Nephrogenic systemic fibrosis Gadolinium Magnetic resonance imaging Renal failure Gadoversetamide Chemistry Nephrology Matter
29	EU PSUR Work Sharing Summary Assessment Report PROHANCE® (Gadoteridol) DK/H/PSUR[removed]P-RMS: Add to Reading List Source URL: www.hma.eu Language: English - Date: 2014-03-04 09:54:10 Nephrology Gadoteridol Magnetic resonance imaging Actuarial science Pharmacovigilance Anaphylaxis Minimisation Risk Medicine Health Nephrogenic systemic fibrosis
30	EU PSUR WORK SHARING SUMMARY ASSESSMENT REPORT DK/H/PSUR[removed]P-RMS: Invented name of the medicinal Add to Reading List Source URL: www.hma.eu Language: English - Date: 2014-03-04 09:54:09 Magnetic resonance imaging Chemistry Nephrogenic systemic fibrosis Bioavailability Fibrosis Medicine Gadodiamide Health